Clinical Trials in Tokyo Bunkyo-ku, Japan
Locations / Tokyo Bunkyo-ku, Japan
Delta Trials hosts 49 clinical trials conducted in Tokyo Bunkyo-ku, Japan, making it a notable site of clinical research activity. These trials covering 36 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 3 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Tokyo Bunkyo-ku.
49
Total Trials
36
Conditions
3
Terminated since 2020
Browse by condition (36 total)
- Idiopathic pulmonary fibrosis 5 trialsAll Idiopathic pulmonary fibrosis trials
- Lung diseases, interstitial 4 trialsAll Lung diseases, interstitial trials
- Parkinson's disease 4 trialsAll Parkinson's disease trials
- All Pulmonary disease, chronic obstructive trials
- Scleroderma, systemic 2 trialsAll Scleroderma, systemic trials
- Lupus nephritis 2 trialsAll Lupus nephritis trials
- Hypertension 2 trialsAll Hypertension trials
- Colitis, ulcerative 2 trialsAll Colitis, ulcerative trials
- Atrial fibrillation 2 trialsAll Atrial fibrillation trials
- Schizophrenia 2 trialsAll Schizophrenia trials
- Chronic kidney disease 2 trialsAll Chronic kidney disease trials
- Systemic lupus erythematosus 1 trialAll Systemic lupus erythematosus trials
- All Systemic autoimmune rheumatic diseases associated interstitial lung diseases trials
- Bronchiectasis 1 trialAll Bronchiectasis trials
- Diabetic nephropathies 1 trialAll Diabetic nephropathies trials
- Diabetes mellitus, type 2 1 trialAll Diabetes mellitus, type 2 trials
- Kidney disease, chronic 1 trialAll Kidney disease, chronic trials
- Systemic sclerosis 1 trialAll Systemic sclerosis trials
- Progressive pulmonary fibrosis 1 trialAll Progressive pulmonary fibrosis trials
- Carcinoma, non-small-cell lung 1 trialAll Carcinoma, non-small-cell lung trials